Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Completed · Not applicable

Conditions studied: Adult Primary Liver Cancer, Kidney Tumor

In brief

This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.

Key facts

Study ID

NCT01908166

Run by

Stanford University

People needed

61

Starts

2014-01-01

Expected to finish

2016-11-01

Last updated by the study team

2017-06-08

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• There are no restrictions on life expectancy
• Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed
• Patients of any ethnic background
• Ability to understand and the willingness to sign a written informed consent document

You may not qualify if…

• Patients should not be taking other investigational agents
• No requirements due to co-morbid disease or intercurrent illness, as needed
• No restrictions on allergic reactions as no imaging agent will be used
• Concomitant medications for treatment of the target lesion
• Pregnant or nursing patients will be excluded from the study

Where it is running

• Stanford University, School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.